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Background and Purpose: Gastric pacemaker cells, interstitial cells of Cajal (ICC), are
believed to initiate myogenic (non-neuronal) contractions. These become damaged in
gastroparesis, associated with dysrhythmic electrical activity and nausea. We utilised
mouse isolated stomach to model myogenic contractions and investigate their origin
and actions of interstitial cells of Cajal modulators.
Experimental Approach: Intraluminal pressure was recorded following distension
with a physiological volume; tone, contraction amplitude and frequency were quanti-
fied. Compounds were bath applied.
Key Results: The stomach exhibited regular large amplitude contractions (median
amplitude 9.0 [4.7–14.8] cmH2O, frequency 2.9 [2.5–3.4] c.p.m; n = 20), appearing
to progress aborally. Tetrodotoxin (TTX, 106 M) had no effect on tone, frequency or
amplitude but blocked responses to nerve stimulation. ω-conotoxin GVIA (107 M) ±
TTX was without effect on baseline motility. In the presence of TTX, (1) atropine
(1010–106 M) reduced contraction amplitude and frequency in a concentration-
related manner (pIC50 7.5 ± 0.3 M for amplitude), (2) CaCC channel (previously
ANO1) inhibitors MONNA and CaCCinh-A01 reduced contraction amplitude
(significant at 105, 104 M respectively) and frequency (significant at 105 M), and
(3), neostigmine (105 M) evoked a large, variable, increase in contraction amplitude,
reduced by atropine (108–106 M) but unaffected (exploratory study) by the H1
receptor antagonist mepyramine (106 M).
Conclusions and Implications: The distended mouse stomach exhibited myogenic
contractions, resistant to blockade of neural activity by TTX. In the presence of TTX,
these contractions were prevented or reduced by compounds blocking interstitial
Abbreviations: CaCC, calcium-activated chloride channel; CTX, ω-conotoxin GVIA; GISMCA, Gastrointestinal Smooth Muscle Contraction Analysis; ICC, interstitial cells of Cajal; LALF, large
amplitude, low frequency; MONNA, N-((4-methoxy)-2-naphthyl)-5-nitroanthranilic acid; pIC50, negative logarithm10 of the half-maximal inhibitory concentration; SAHF, small amplitude, high
frequency; TTX, tetrodotoxin.
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cells of Cajal activity or by atropine and enhanced by neostigmine (antagonised by
atropine), suggesting involvement of non-neuronal ACh in their regulation.
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1 | INTRODUCTION
Gastric contractions depend on functional interactions between the
vagus nerve, enteric nerves and interstitial cells of Cajal (ICC) (Goyal
et al., 2019). Within the gastric body and antrum, the ICC act as pace-
makers, spontaneously depolarising to generate regular, slow waves
of electrical activity, conducted to the smooth muscle to depolarise
and thereby initiate or facilitate rhythmic myogenic contractions
(Sanders, 2020). However, whilst the electrical properties of the ICC
and smooth muscle have been extensively studied, the relationships
between ICC activity and the resultant myogenic contractions are less
well understood. Where this has been investigated, muscle strips or
sheets (usually with mucosa removed) from laboratory animals were
used, to record electrical activity directly from the ICC in addition to
the electrical and mechanical activity (tension) of the smooth muscle.
These studies included the mouse (Forrest et al., 2006; Hwang
et al., 2016, 2019; Worth et al., 2015) and the guinea pig stomach
(Edwards & Hirst, 2006; Hashitani et al., 2005; Hirst & Edwards, 2006).
However, the actions of compounds modulating electrical activity
within the ICC have not always correlated with anticipated changes in
mechanical or myogenic contractile activity of muscle strips (Boddy
et al., 2004). An additional complication in understanding the relation-
ships between ICC and muscle functions is illustrated by recent
recordings of gastric myoelectric activity from the entire mouse and
house musk shrew stomach in vitro (Liu et al., 2019). Such techniques
require suppression of contractile activity by calcium channel antago-
nists as does recording of transmembrane potentials in the ICC and
smooth muscle using microelectrodes. Together, these difficulties sug-
gest a need to obtain a greater understanding of myogenic contractile
activity in intact stomach preparations, both to establish a baseline of
activity for comparison with electrical activity of the ICC and to facili-
tate the study of drugs and disease that modulate gastric movements.
We utilised an in vitro mouse whole stomach preparation to inves-
tigate and characterise rhythmic spontaneous contractions by record-
ing intragastric pressure. The mouse was chosen as although its gastric
morphology differs markedly from humans (e.g. location of the entry of
the oesophagus and the aglandular proximal stomach) and is unable to
vomit (associated with different brainstem connectivity and the
absence of key endocrine and signalling pathways) (Horn et al., 2013;
Sanger et al., 2011), it is nevertheless the species, together with the
guinea pig, in which ICC functions have been studied in most detail
(see Section 4 for references). Additionally, the mouse is readily amena-
ble to molecular modification to study gastric motility (e.g. Mule &
Serio, 2002). Intraluminal pressure was recorded via a cannula inserted
into the stomach through the duodenum, preventing gastric emptying.
The aims were to (1), record and characterise rhythmic gastric muscle
contractions following distension with a physiological volume of fluid,
(2) pharmacologically isolate a myogenic (non-neuronal) component of
the gastric contractions (following administration of the Nav channel
blocker tetrodotoxin [TTX]) and (3), investigate the involvement of ICC
activity in generating myogenic contractions in the intact stomach. As
the calcium-activated chloride channel (CaCC), previously known as
anoctamin-1 (Alexander et al., 2021), is a specific marker for ICCs in
the mouse and human digestive tract (Gomez-Pinilla et al., 2009), we
investigated compounds that block this channel, namely, CaCCinh
-A01 (Namkung et al., 2011) and N-((4-methoxy)-2-naphthyl)-
5-nitroanthranilic acid (MONNA; Oh et al., 2013, 2008). The results
unexpectedly identified a control mechanism within the whole stomach
involving non-neuronal ACh, not previously reported when using mus-
cle strips. The latter has implications in understanding mechanisms by
which gastric motility is controlled and disrupted during disorders in
which nausea and dysrhythmic gastric electrical activity are reported
(O'Grady et al., 2014).
What is already known
• Depolarisation of interstitial cells of Cajal (ICC) expressing
calcium-activated chloride channels (CaCC) initiates
gastric contractions.
• In whole stomach, mechanisms regulating phasic
‘myogenic’ contractions (not neurally mediated) are
poorly characterised.
What this study adds
• Large amplitude, low frequency myogenic contractions of
the stomach are attenuated by CaCC channel block.
• Atropine blocks myogenic contractions, implicating tonic
release of ACh from non-neuronal sources in their
regulation.
What is the clinical significance
• Cooperativity between gastric ICC activity and non-
neuronal ACh is a novel mechanism.
• Muscarinic receptor antagonism may influence gastric
dysmotility associated with damaged ICCs (e.g.
gastroparesis).
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2 | METHODS
2.1 | Animals
The study used 20 male and 20 female CD1 mice (25–35 g;
6–7 weeks old; randomly assigned to experimental groups of equal
size except where exploratory studies were undertaken) obtained
from Charles River UK Ltd. and housed in single sex groups (five ani-
mals per cage, cage size 194 mm  181 mm  398 mm; Allentown
Inc, UK) with lignocel bedding (shredded nesting and envirotube), ad
libitum access to pelleted food (5R58 irradiated diet; Labdiet®, IPS
Products Supplies Ltd, UK) and water, in a light (07.00–19.00), tem-
perature (21 ± 2C) and humidity (55% ± 5.5%) controlled room. The
mice were killed by cervical dislocation following the guidelines of our
institutional Animal Ethics Committee in compliance with Annexe IV
of EU 2010/63 and the UK, Animals (Scientific Procedures) Act 1986.
Animal studies are reported in compliance with parts of the ARRIVE
guidelines (Percie du Sert et al., 2020) and with the recommendations
made by the British Journal of Pharmacology (Lilley et al., 2020) where
these relate to in vitro studies using animal tissue.
2.2 | Measurement of intragastric pressure
After opening the abdomen, the stomach was removed with the dis-
tal oesophagus and proximal small intestine (5 cm) attached and
placed in a Sylgard 184 (Dow Corning Corp, USA)-lined chamber
(50 ml) containing modified Krebs' solution (see below) gassed with
95% O2/5% CO2 and maintained at 37C (TC120, Grant Instru-
ments). A small, longitudinal incision (3–5 mm) was made in the
proximal forestomach along the greater curve to facilitate removal
of gastric contents by flushing with modified Krebs' solution. The
oesophagus was ligated at the gastro-oesophageal junction and the
forestomach incision closed with a ligature. A cannula (1.3-mm
external diameter) filled with Krebs' solution was inserted into the
stomach via the remnant duodenum (<1 cm) and secured with a lig-
ature at the gastro-duodenal junction; the cannula tip was located
in the antrum 5 mm from the ligature. Intragastric pressure was
monitored following distension with 0.3-ml modified Krebs' solution
(a volume within the range measured post-prandially in pilot studies)
using a pressure transducer (TSD104A, BIOPAC System Inc., UK)
connected to a DA 100C amplifier (BIOPAC System Inc) and data
recorder (MP100A, BIOPAC System Inc), with the output displayed
on a computer (Dell OptiPlex 7460). Pressure recording began
30 min after removing the stomach from the animal. The trans-
ducer was mounted at the same level as the Sylgard-lined base of
the tissue bath and ‘zero pressure’ defined as the pressure
measured by the transducer open to atmosphere. The effects of dif-
ferent compounds on the pressure changes were measured follow-
ing their application to the solution bathing the serosa. No further
injections of Krebs' solution were made into the stomach lumen
throughout the experiment.
2.3 | Motility analysis
Two methods were used for analysis of pressure recordings. Firstly, a
manual method (see below) measured baseline parameters (tone, con-
traction amplitudes and frequency; see below). These data defined prep-
aration stability and were used to determine the effect of TTX. Secondly,
an automated analysis (Gastrointestinal Smooth Muscle Contraction
Analysis, see below) was used to average contraction waveforms and for
comparison of changes in amplitude and frequency of the ‘large
amplitude, low frequency’ (LALF) myogenic contractions (see Section 3)
following administration of drugs in the presence of TTX.
2.3.1 | Manual method
This was undertaken by direct measurement (using a cursor) from the
original recordings of the different parameters. The raw data (tone,
contraction amplitude and frequency) before and after application of
TTX, and in stomachs without TTX treatment over a comparable time
period, were analysed based upon the average of measurements at
specific time points and periods. The parameters are defined below.
• Tone: The prevailing pressure difference in cmH2O between atmo-
spheric zero and the level upon which rhythmic contractions were
superimposed, measured at three time points (10, 20 and 30 min)
before and after (40, 50 and 60 min) TTX.
• Contraction amplitude: This is the difference in pressure between
the tone and the peak pressure achieved during a contraction. The
amplitudes of the last 10 consecutive LALF contractions
(see Section 3.1) were measured between 10 and 20 min and
20–30 min pre-TTX, with another 10 contractions measured post-
TTX between 40–50 and 50–60 min. These were averaged for
each stomach to represent the amplitude of contractions pre- and
post-TTX application. Rhythmic contractions occurring in the pres-
ence of TTX are defined as ‘myogenic’ (Costa et al., 2013; Dinning
et al., 2012).
• Contraction frequency: The number of LALF contractions
(see Section 3.1) during specified 10-min periods expressed as con-
tractions per minute (c.p.m.).
2.3.2 | Automated analysis
Contractile activity was analysed using Gastrointestinal Smooth Mus-
cle Contraction Analysis (GISMCA, Version 0.4.1; https://github.com/
agharibans/GISMCA/tree/master/GISMCA) software.
The motility parameters measured were defined exactly as in the
manual analysis described above, using the GISMCA programme
default setting (in which contractions were automatically identified
and analysed only if the detected peaks were above the minimum
amplitude of 0.05 cmH2O and interpeak interval was 10 s). Time
periods for analysis were defined by drug administration protocols
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(see below) with the data on LALF contraction amplitude and fre-
quency, and tone used to define the effects of drugs in the presence
of TTX. The average value of the contraction amplitude and tone from
the last five consecutive LALF contractions during each selected
period of analysis (post-TTX [myogenic], post-each drug concentra-
tion) was used to quantify the effect of drug treatments on myogenic
activity (i.e., in the presence of TTX). The automated analysis averaged
contractions in the selected periods to produce a single contraction
profile with a shadow showing the SEM. Frequency was measured
over 10-min periods, as above.
The effects of drugs are expressed as a percentage of the mea-
surements made in the presence of TTX alone (106 M) or TTX
+ neostigmine (105 M) (assigned a value of 100%), prior to their
addition (see below). The effects of atropine displayed a sigmoidal
concentration–response curve, so a pIC50 (the negative logarithm10 of
the half-maximal inhibitory concentration) was calculated for all
parameters. For other drugs, the relationship was not sigmoidal so
data are presented as histograms.
2.4 | Nerve stimulation
A limited number of experiments investigated the effect of TTX (106 M)
and ω-conotoxin GVIA (CTX; 107–1.3  106 M) on the gastric motil-
ity response to stimulation of electrodes placed around the distal
oesophagus (bipolar platinum wire ring electrodes, likely to stimulate
vagal nerve fibres and possibly, enteric neurones; n= 6) or across the wall
of the stomach (transmural stimulation, using 10-mm-long bipolar plati-
num prong electrodes; one pole inside the stomach via the fundic incision
and the other adjacent to the serosa; n = 5), each at 5- and 10-Hz fre-
quency, 0.5-ms pulse width, up to 25 V (to elicit a maximal response at
the frequencies used) for 60 s using a S88 stimulator, Grass Instrument
Co., USA. These parameters were comparable with those used in similar
mouse stomach preparations (Black & Shankley, 1985; Welsh
et al., 1993).
2.5 | Protocol
Group size (n = 5) for investigating each potential modulator of myo-
genic contractions was selected based on the minimum number of
mice, which Curtis et al. (2018) consider can be used to obtain a valid
statistical analysis and is consistent with the minimal number of four
to six mice used in comparable published studies (e.g. Mule &
Serio, 2002; Worth et al., 2015).
Tissue manipulation was performed in Krebs' solution ( 103M:
NaCl, 118.3; KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; glucose, 11.1;
NaHCO3, 25; CaCl2, 2.5) modified by addition of the H
+/K+ ATPase
inhibitor omeprazole (106 M) to reduce gastric acid secretion, vol-
ume change and possible mucosal damage (Coruzzi et al., 1986). A
pilot study showed that when added to Krebs' solution separately, this
concentration was the maximum possible without affecting motility.
The Krebs' solution was gassed with 95% O2/5% CO2 and maintained
at 37C. Although pilot studies showed that preparations were viable
for 3.5 h, most studies were confined to 2 h to ensure stability of
baseline parameters.
The pharmacology of the contractions was investigated during the
presence of TTX (30 min after application of TTX 106 M) by adding
increasing concentrations of atropine to the bathing solution (n = 5;
1010–106 M) or the CaCC antagonists CaCCinh-A01 (n = 5; 10
10–
105 M) and MONNA (n = 5; 109–104 M), with 15 min between
each increase in concentration. After pilot experiments establishing
the duration of the response to neostigmine (105 M), it was added to
the bathing solution 30 min after TTX (106 M) and left to equilibrate
for 15–30 min prior to adding incremental concentrations of atropine
(n = 5; 109–106 M) with 15 min between each concentration. We
investigated the potential role of histamine (H1) receptors in the
response to neostigmine using mepyramine (n = 3; 106–104 M),
added to the bathing solution with 15 min between each
concentration. However, because effects were observed only at con-
centrations considered non-selective, we limited the study to n = 3
(precluding statistical analysis) but show all data points and an
example of an original record. The effects of CTX (107 M) were inves-
tigated at least 30 min after application as prolonged contact times are
required to achieve maximal activity in rat and guinea pig tissues
(Sanger et al., 2000).
2.6 | Materials
CaCCinh-A01 and MONNA were obtained from Tocris Bioscience,
UK. Atropine sulphate, neostigmine bromide, omeprazole, TTX and
CTX were from Sigma, Dorset, UK. Mepyramine maleate was from
Cambridge Bioscience, UK. MONNA and CaCCinh-A01 were dissolved
in DMSO and atropine in 50% ethanol; the maximum final concentra-
tions of DMSO and ethanol in the bathing solution were 0.1% and
0.02%, respectively, and were without effect at these concentrations.
Neostigmine bromide, TTX and CTX were dissolved in double distilled
water. Omeprazole was dissolved in Krebs' solution. DMSO and all
other regents such as those for preparing Krebs' solution were from
Fisher Scientific, UK.
2.7 | Data analysis and statistics
Analysis of recordings was undertaken in the knowledge of the drug
treatment applied to each stomach in vitro. Although the analysis was
not blinded (i.e. the drug applied was identified in the recording file), a
large proportion of data analysis used an automated method indepen-
dent of the operator and all analysed data were checked by another
researcher. No data were excluded, and all data points are presented
in the figures. For each drug, an example of an original recording is
shown to support the validity of the numerical data.
Baseline motility data (contraction amplitude, frequency and
tone) pre- and post-TTX (Figure 1) are presented (figures or text)
in the original units (cmH2O and c.p.m.). To illustrate the
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concentration-related activity of drugs, the magnitude of which
may depend upon baseline values, we normalised the effects of
atropine, MONNA and CaCCinh-A01 (which were inhibitory) as a
percentage of the post-TTX baseline values for each stomach in
that group, using these values for statistical analysis (Figures 2–4).
Similarly, the inhibitory effects of increasing concentrations of atro-
pine on the excitatory response to neostigmine (in the presence of
TTX) were normalised relative to the neostigmine (% neostigmine
+ TTX; Figure 5).
The declared group size is the number of independent values; sta-
tistical analysis was done using these independent values and was
only undertaken where group size was ≥5. Data in the text are
reported as median with interquartile range in parentheses
(n = number of stomachs) and in histograms as medians with all
individual data points shown, and in Figure 1 as medians with
interquartile range and all data points. Calculations were made using
Microsoft Excel (Microsoft Excel, RRID:SCR_016137) and GraphPad
Prism Version 8 or 9 (GraphPad Prism, RRID:SCR_002798; GraphPad
Software, USA) also used for plotting histograms. Statistical compari-
sons of the effects of increasing concentrations of drug on each
parameter (amplitude, frequency and tone) were undertaken by com-
paring the value normalised to the baseline value in the presence of
TTX (100%) using the non-parametric Friedman test (matched samples
where assumption of equal variances is not applicable) with Dunn's
multiple comparison test. For specific data sets, a Mann–Whitney test
was used for comparison. Statistical significance throughout was
P < 0.05.
For the cumulative concentration–response study of the effects
of atropine following TTX (Section 2.5), a sigmoidal log10 (inhibitor)
concentration–response curve was fitted using a four-parameter
logistic equation with automatic outlier elimination using GraphPad
Prism Version 8.0 (GraphPad Prism, RRID:SCR_002798; GraphPad
Software). pIC50 values are reported as mean ± SEM (n = number of
stomachs).
The manuscript complies with the British Journal of
Pharmacology's recommendations and requirements on experimental
design and analysis (Curtis et al., 2018).
2.8 | Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to
corresponding entries in the IUPHAR/BPS Guide to PHARMACOLOGY
http://www.guidetopharmacology.org and are permanently archived in
the Concise Guide to PHARMACOLOGY 2021/22 (Alexander
et al., 2021).
F IGURE 1 Baseline analysis of the mouse isolated stomach spontaneous contractions pre- and post-tetrodotoxin (TTX). (a) The spontaneous
contractions pre- and post-TTX (106 M) administration. Black arrows show the small amplitude, high frequency (SAHF) contractions, between
and superimposed upon the high amplitude, low frequency (LALF) contractions. (b) Analysis (see Section 2.3.1) of the spontaneous contraction
amplitude (LALF) and frequency from 20 preparations pre-TTX and post-TTX (106 M) administration (see Section 2 for details) and 7 time-
matched (periods A and B) preparations not treated with TTX. The median value and interquartile ranges are shown together with the individual
data points. (c) An example of the pressure record averaged (see Section 2.3.2) over 10 min before TTX and between 20 and 30 min after TTX
(106 M). The solid line and the shadow represent the average and the SEM value, respectively. Time 0 corresponds to the peak of each
contraction. (d) Representative recording showing block of electrical stimulation (circumoesophageal electrodes 10 Hz, 0.5 ms, 20 V, 1 min,
horizontal bar) induced reduction in tone and abolition of contractions by TTX (106 M)
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3 | RESULTS
3.1 | Characterisation of baseline motility
Immediately on placing the stomach in the tissue bath, rhythmic con-
tractile activity, passing as a deepening ring wavefront from the proxi-
mal to the distal stomach, became visible and continued following
distension with a physiological volume (0.3 ml; see Section 2.2) of
Krebs' solution. Inspection of the pressure recordings following dis-
tension revealed two types of contractile activity with differing ampli-
tudes and frequencies. Based on analysis of baseline recordings from
20 stomachs prior to application of TTX (see below), the most promi-
nent contractions were LALF (Figure 1a). These had an amplitude of
9.0 (4.7–14.8) cmH2O and frequency of 2.9 (2.5–3.4) c.p.m. (n = 20).
Smaller (<1 cmH2O) contractions were also visible with a higher
frequency (>5 c.p.m). These ‘small amplitude, high frequency’ (SAHF)
contractions were manifest in the pressure record as oscillations visi-
ble between the LALF contractions and also superimposed on the
larger contractions giving some a serrated appearance (Figure 1a).
Close inspection of 10 large amplitude contractions from each of
20 stomachs (in the 10 min immediately prior to TTX) revealed that in
all stomachs the ‘large’ contractions were recorded but ‘small’ con-
tractions were apparent in 75% of stomachs. Of these, 63%
(126/200) of LALF contractions had SAHF contractions visible as a
serration on the contraction and/or present between the larger con-
tractions. Analysis of the SAHF contractions over a 5-min period from
10 animals in which these contractions were clearly recorded
(between or superimposed upon the larger contractions) identified a
frequency for the large contractions of 3.0 (2.4–3.7) c.p.m., but when
all contractions (small and large) were counted, the overall frequency
was 8.8 (6.8–9.3) c.p.m. When determining the effects of TTX and
other drugs, this study confined itself to the prominent, consistently
recorded LALF contractions for quantitative analysis.
3.2 | Effect of tetrodotoxin (TTX) and ω-conotoxin
GVIA (CTX) alone and in combination
Comparison of baseline motility data with that in the presence of TTX
(106 M) using 20 stomachs revealed that TTX had no effect on
F IGURE 2 Antagonism of mouse stomach myogenic contractions by atropine. (a) Examples of the pressure record averaged following
incremental concentrations of atropine in the presence of TTX (106 M; see Section 2.3.2 for analysis). The solid line represents the average, and
the shadow illustrates the SEM. Time 0 corresponds to the peak of each contraction. (b) Examples of 5-min segments of original pressure
recordings showing the effect of incremental concentrations of atropine in the presence of tetrodotoxin (TTX; 106 M). (c) Concentration–
response curves for the effect of atropine on the contraction amplitude, frequency and tone relative to the baseline values in the presence of TTX
(106 M). Individual values are plotted together with the best fit curve (n = 5). Friedman's test/Dunn's comparison of each atropine concentration
with TTX; *P < 0.05
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contraction amplitude or frequency when compared with time-matched
controls (Figure 1a,b). Further, the profile of averaged contractions
(Figure 1c) measured using automated analysis revealed no change in
the shape of the LALF contractions with TTX. Inspection of the record-
ings showed that SAHF contractions were also present following TTX
(Figure 1a), but as noted above, quantification of these contractions was
not undertaken.
Electrical nerve stimulation (electrodes around oesophagus [n
= 6] and positioned transmurally [n = 5], stimulated at 5 and
10 Hz for 60 s) was used to evaluate the efficacy of TTX (106 M),
in blocking nerve-mediated activity. Both stimulation methods
reduced gastric tone and markedly reduced the amplitude of
ongoing rhythmic contractions, and these responses were abolished
by TTX (see Figure 1d for example using circumoesophageal
electrodes).
The effects of TTX do not preclude the spontaneous release of
ACh from nerve terminals, so the effects of CTX (107–1.3  106 M)
were investigated. Addition of CTX (107 M; n = 7) was without sig-
nificant effect on the averaged spontaneous contraction waveform or
motility parameters when given alone or in the presence of
subsequently administered TTX (106 M) (Figure S1). CTX (107–
1.3  106 M) also failed to prevent the inhibitory response to electri-
cal nerve stimulation (Figures S2 and S3). TTX (106 M) administered
after application of CTX blocked the inhibitory responses to electrical
nerve stimulation (Figure S3).
3.3 | Effect of atropine in the presence of TTX
Addition of atropine (1010–106 M) to stomachs treated with TTX
(106 M) reduced the amplitude of spontaneous contractions with the
effect particularly marked at ≥107 M (90% inhibition), when tone
was also reduced (40%); at 106 M, contractions were virtually
undetectable (Figure 2a,b). The log10 concentration–response curves
for all parameters were approximately sigmoidal, with pIC50 values of
7.5 ± 0.3, 6.9 ± 0.3 and 7.4 ± 0.2 (not significantly different; n = 5) for
the effect of atropine on contraction amplitude, frequency and tone,
respectively (Figure 2c).
F IGURE 3 Antagonism of mouse stomach myogenic contractions by the calcium activated chloride channel (CaCC) inhibitor (CaCCinh-A01).
(a) Examples of the pressure record averaged following incremental concentrations of CaCCinh-A01 in the presence of tetrodotoxin (TTX; 10
6
M; see Section 2.3.2 for analysis). The solid line represents the average, and the shadow illustrates the SEM. Time 0 corresponds to the peak of
each contraction. (b) Examples of 5-min segments of original pressure recordings showing the effect of incremental concentrations of CaCCinh
-A01 in the presence of TTX (106 M). (c) Concentration–response curves for the effect of CaCCinh-A01 on the contraction amplitude, frequency
and tone relative to the baseline values in the presence of TTX (106 M). Values are median with all individual values plotted (n = 5). Friedman's
test/Dunn's comparison of all concentrations of CaCCinh-A01 with TTX (see Section 2.7); *P < 0.05
CAI ET AL. 7
3.4 | Effect of CaCCinh-A01 in the presence of TTX
CaCCinh-A01 had no statistically significant effects on contraction
amplitude until a concentration of ≥106 M was reached (Figure 3a,b).
CaCCinh-A01 at 10
5 M significantly reduced the contraction fre-
quency (50% inhibition) and tone (40%) (Figure 3c).
3.5 | Effect of MONNA in the presence of TTX
Lower concentrations of MONNA (109–105 M) were without sta-
tistically significant effects on contraction amplitude, but frequency
was significantly reduced at ≥105 M. MONNA at 104 M signifi-
cantly reduced contraction amplitude (80% inhibition) and frequency
(60%), also tending to reduce tone (20%) (Figure 4a–c).
3.6 | Effect of neostigmine in the presence of TTX
Although the myogenic contractions were markedly reduced in ampli-
tude in a concentration-related manner by atropine in the presence of
TTX (Section 3.3), additional evidence for an involvement of ACh in
these contractions was sought by investigating the effects of the cho-
linesterase inhibitor neostigmine. Because of closure of the laboratory
(Covid-19 pandemic restrictions), these studies were undertaken
several months after the other studies reported. Compared with the
earlier studies, the baseline contraction amplitude (i.e. post-TTX and
pre-neostigmine) and tone were both lower and in the case of ampli-
tude, more variable (respectively for the two groups: 8.0 [5.0–13.0]
cmH2O vs. 1.4 [0.9–27.1] cmH2O, and 4.3 [3.0–6.3] cmH2O vs. 3.1
[2.8–4.8] cmH2O; n = 20 original group and 8 new group used to test
neostigmine) although the differences did not achieve statistical
significance. However, the contraction frequency (respectively 2.8
[2.4–3.4] c.p.m. vs. 3.6 [3.4–3.8] c.p.m.) was significantly greater
between the two groups.
In the presence of TTX (106 M), neostigmine (105 M;
Figure 5a) produced an increase in tone with a rapid onset and
was of variable magnitude (δ 1.3 [0.9–1.9] cmH2O; n = 8) upon
which were superimposed rhythmic contractions with an increased
amplitude (δ 7.6 [6.2–12.6] cmH2O; N = 8) but unchanged fre-
quency (δ 0.00 [0.15 to 0.00] c.p.m.; n = 8). The response lasted
at least 30 min.
F IGURE 4 Antagonism of mouse stomach myogenic contractions by the calcium activated chloride channel (CaCC) inhibitor (MONNA).
(a) Examples of the pressure record averaged following incremental concentrations of MONNA in the presence of tetrodotoxin (TTX; 106 M; see
Section 2.3.2 for analysis). The solid line represents the average, and the shadow illustrates the SEM. Time 0 corresponds to the peak of each
contraction. (b) Examples of 5-min segments of original pressure recordings showing the effect of incremental concentrations of MONNA in the
presence of TTX (106 M). (c) Concentration–response curves for the effect of MONNA on the contraction amplitude, frequency and tone
relative to the baseline values in the presence of TTX (106 M). Values are median with all individual values plotted (n = 5). Friedman's test/
Dunn's comparison of all concentrations of MONNA with TTX (see Section 2.7); *P < 0.05
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3.7 | The effect of atropine and mepyramine on
the response to neostigmine in the presence of TTX
In five stomachs treated with neostigmine (see Section 3.6), the
effect of incremental concentrations of atropine was investigated
(Figure 5a,b). The increase in contraction amplitude and tone induced
by neostigmine was significantly reduced by atropine at 106 M.
Contraction frequency tended to be reduced by 106 M of atropine,
but this was not statistically significant (Figure 5b).
As histamine is a potent stimulant of gastric contractions (via
H1 receptors) and is present in the stomach in large amounts (see
Section 4), we hypothesised that it might also be involved in the
non-neuronal responses together with ACh. However, in these pre-
liminary studies using stomachs treated with TTX alone (106 M),
the enhanced contraction amplitude response to neostigmine
appeared unaffected by mepyramine (106 M; n = 3), although
reduced in an apparently concentration-related manner at higher
concentrations (105, 104 M; n= 3) (Figure 6a,b); the neostigmine-
induced increase in tone and contraction frequency appeared
unchanged (Figure 6b).
4 | DISCUSSION
Large amplitude, low frequency (LALF) contractions of mouse whole
stomach occurred without TTX-sensitive neuronal control, by a
mechanism likely dependent on spontaneous depolarisation of pace-
maker cells, perhaps enhanced by the physiological distension of the
stomach (mouse stomach intramuscular interstitial cells of Cajal (ICCs)
are stretch sensitive; Won et al., 2005). This conclusion has some con-
sistency with Beckett et al. (2003), who recorded slow wave electrical
activity in mouse gastric antrum during the presence of TTX. How-
ever, in the present study, the contractions were reduced by atropine
and increased by neostigmine in a TTX-resistant manner, suggesting
additional control involving a TTX-insensitive source of ACh.
In the mouse stomach in the presence of TTX, the most
prominent contractions were large amplitude and 3-c.p.m. fre-
quency. Small amplitude, high frequency (SAHF) contractions were
superimposed upon and interspersed between the larger contractions.
Combining both (when both present) gave a frequency of 8 c.p.m.
Thus, the 3–8 c.p.m. range covers the values reported for electrical
recordings of mouse gastric myoelectric (slow wave) activity in the
F IGURE 5 Antagonism of neostigmine enhanced myogenic contractile activity by atropine. (a) An original recording selected to illustrate the
protracted stimulation of contraction amplitude by neostigmine (105 M) in the presence of tetrodotoxin (TTX; 106 M). In this experiment, the
effects of atropine (109–106 M) were investigated 30 min after neostigmine. (b) Quantification of the effect of incremental concentrations of
atropine (109–106 M) on the response to neostigmine (105 M) in the presence of TTX (106 M) with addition of atropine commencing 15 min
after neostigmine (see Section 2). The effect of atropine on contraction amplitude, frequency and tone is plotted in relation to the TTX
+ neostigmine response. Responses are plotted as median with individual values plotted. Friedman's test/Dunn's test comparing responses to
incremental concentrations of atropine to the response to neostigmine in the presence of TTX; *P < 0.05
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corpus (6–8/min; Kim et al., 2003; Liu et al., 2019; Worth
et al., 2015) and antrum (3–4/min; Forrest et al., 2006; Hwang
et al., 2016; Kim et al., 2003; Sanders, 2020), and also the contraction
frequency in antrum circular muscle (3.6 ± 0.5 c.p.m.; Hwang
et al., 2019). We hypothesise that the higher frequency SAHF con-
tractions reflect activity originating in the proximal stomach, whereas
LALF contractions (see van Helden et al., 2010) reflect antral
contractions.
The LALF contractions were myogenic because of insensitivity to
TTX and CTX (Costa et al., 2013; Dinning et al., 2012). We confirmed
that TTX (106 M) blocked the inhibitory effect of electrical nerve
stimulation on mouse stomach contractility, consistent with blockade
of nerve-mediated acid secretion by TTX in mouse stomach (Angus &
Black, 1982) and effects on gastrointestinal (GI) movements
(e.g. Costa et al., 2013; Hibberd et al., 2017; Mule & Serio, 2002). A
limitation of the experiments with CTX was that its ability to block
nerve-mediated responses was not confirmed when using the same
protocol (but see below for discussion).
The lack of effect of TTX (and CTX) on contractions concords
with the slow wave electrical activity in mouse gastric antrum
recorded during the presence of TTX (Beckett et al., 2003). Neverthe-
less, enteric nerve reflexes are triggered during the dynamic phase of
gastric distension in guinea pig isolated stomach (Hennig et al., 1997).
Accordingly, it remains a possibility that spontaneous enteric nerve
activity could occur via TTX-resistant Nav channels (Bartoo
et al., 2005) or calcium channels involved in neurotransmitter release
(Waterman, 2000). Further studies with neurotoxins are required (see
below).
Pacemaker cells were involved in generating the LALF myogenic
contractions. Thus, in the presence of TTX, the CaCC inhibitors
MONNA and CaCCinh-A01 each reduced contraction amplitude and
frequency, with significant effects at the higher concentrations. For
CaCCinh-A01, the effective concentrations were in the range that
reduced frequency and duration of mouse gastric antral electrical slow
waves (Hwang et al., 2016, 2019), implicating the ICC in their origin.
The highest concentrations of MONNA and CaCCinh-A01 also
reduced muscle tone. These compounds (107–105 M) have also
been shown to relax noradrenaline or U46619-induced mouse vaso-
constriction in a Cl-free environment, suggesting activity additional
to CaCC blockade (Boedtkjer et al., 2015).
ACh may be involved in generation of LALF myogenic contrac-
tions. Thus, the >90% reduction in contraction amplitude by atropine
in the presence of TTX suggests a tonic release of ACh, possibly from
non-neuronal sources. An action on the ICCs is supported by electro-
physiological studies of mouse cultured ICC (Kim et al., 2003) and
mouse stomach cholinergic transmission (Sung et al., 2018).
Elsewhere, in rat isolated stomach, it has been suggested that the gen-
eration of contractions is dependent on cholinergic nerve activity
(Zhang et al., 2011). However, cholinergic activity was defined by use
of only atropine and not by further study with neuronal toxins. In flat
sheet preparations of mouse gastric antrum or corpus antrum, mea-
suring slow wave electrical activity in the presence of nifedipine, the
frequency and propagation of slow waves were increased by electrical
field stimulation (EFS) or neostigmine, both blocked by muscarinic
antagonism or by TTX/hexamethonium (Forrest et al., 2006; Worth
et al., 2015). A previous study (Beckett et al., 2003) showed an ability
F IGURE 6 Preliminary experiments showing the effect of mepyramine on the response to neostigmine in the presence of tetrodotoxin (TTX).
(a) Examples of 5-min segments of original pressure recordings showing the effect of incremental concentrations of mepyramine (106–104 M)
on the response to neostigmine (105 M) in the presence of TTX (106 M). (b) Concentration–response curves for the effect of mepyramine on
the contraction amplitude, frequency and tone relative to values in the presence of neostigmine (105 M) and TTX (106 M). Responses are
plotted as median with all individual values shown (n = 3)
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to detect slow wave activity during the presence of atropine or TTX,
so the experiments with neostigmine enabled Forrest et al. (2006) to
suggest the existence of an ongoing spontaneous release of ACh
(from a neural source and/or affecting neuronal function), the assump-
tion being that endogenous AChE activity ‘neutralised’ the released
ACh during baseline conditions.
In the present experiments, in the presence of TTX, neostigmine
increased the amplitude of the LALF contractions. The prolonged
facilitation is consistent with a tonic release of ACh, further supported
by the atropine sensitivity of the response, which was of comparable
magnitude with that of atropine on baseline activity in the presence
of TTX. Worth et al. (2015) also found an atropine-sensitive increase
by neostigmine of the propagation of contractions in mouse stomach
flat sheets. Moreover, the present experiments find similarity to those
obtained using rat and guinea pig urinary bladder, in which TTX, and
ω-agatoxin IVA and CTX (predominantly Cav2.1 and Cav2.2 channel
blockers)-insensitive spontaneous release of ACh were involved in the
genesis of rhythmic contractions (Zagorodnyuk et al., 2009). In sum-
mary, therefore, we conclude that in mouse isolated stomach, myo-
genic activity may be influenced by non-neuronal ACh. Perhaps, the
contrast with the conclusions of Forrest et al. (2006) may be explained
by the different preparations (whole stomach vs. flat sheet) and mea-
sured endpoints (electrical activity vs. muscle contraction).
Non-neuronal sources of ACh are found in gastro-oesophageal
epithelia and gastrointestinal immune cells, including tuft cells
(Beckmann & Lips, 2013; Cox et al., 2020; Grando et al., 2020;
Schneider et al., 2019; Wessler & Kirkpatrick, 2008; Wolf-Johnston
et al., 2012). The rat colonic epithelium is also a non-neuronal source
of ACh, which is implicated in the regulation of ionic transport and
proposed to be an interface between the colonic microbiome and the
host (Bader et al., 2019; Bader & Diener, 2018). In addition, intramus-
cular ICCs may be a source of paracrine substances, based on consti-
tutive expression of COX-2 (Porcher et al., 2002). Further studies are
required in mouse stomach to identify the hypothesised non-neuronal
source of ACh.
We considered that the released ACh might affect other cells
involved in gastric regulation, such as the enterochromaffin-like or
mast cells in the lamina propria and muscle, both of which release
histamine (Buhner & Schemann, 2012; Hakanson & Sundler, 1991).
Histamine contracts gastric muscle (e.g. Sim et al., 1989) and can
enhance rhythmic contractile activity (Naganuma et al., 2018). How-
ever, the H1 receptor antagonist mepyramine, at a concentration
likely to substantially antagonise H1 receptor functions (10
6 M), in
preliminary experiments had no effect on the motility response to
neostigmine in the presence of TTX. Higher concentrations of
mepyramine, but with affinity for muscarinic receptors (Kubo
et al., 1987), reduced the amplitude of the LALF contractions. These
data suggest that although H1 receptors are expressed by cultured
ICC from murine intestine (Kim et al., 2013) and elsewhere in the
gastrointestinal tract (Sander et al., 2006), they are unlikely to play a
role in the control of myogenic activity. We cannot exclude the
release of other mediators from the mucosa, such as 5-HT from
gastric enterochromaffin cells.
Although we focus above on the origin of the hypothesised non-
neuronal ACh, its potential target(s) should not be overlooked. This is
most likely to be muscarinic receptors located on the ICC
(Sanders, 2020), but the gastric muscle itself cannot be excluded.
4.1 | Study limitations
Recording of intragastric pressure in mouse isolated stomach has been
used infrequently to investigate gastric physiology and pharmacology
(e.g., Mule & Serio, 2002). Although the isolated stomach retains a
high degree of anatomical and functional integrity, the motor behav-
iour will inevitably differ from that in vivo. Nevertheless, intragastric
pressures reflect the overall motor activity (especially when recorded
in a small volume), comprising muscle contractions (particularly the
LALF) and tone, and can therefore be more representative of gastric
physiology than use of muscle strips/sheets, sometimes mucosa free.
Additional studies (e.g. high resolution video recording with pressure
recording, e.g. Berthoud et al., 2002) are needed to investigate
regional motility.
Gastric tone, contraction amplitude and frequency were quanti-
fied, but because more than one contraction may present in different
stomach regions, the frequency may not equate directly to the fre-
quency of pacemaker activity recorded from ICCs using electrophysi-
ology techniques.
Our primary conclusion relies on the effects of TTX and atropine,
supported by findings with other agents presumed to act on the ICCs.
The lack of effect of CTX (107–1.1  106 M) on neuronal functions
blocked by TTX is acknowledged as a limitation to drawing firmer con-
clusions. However, CTX is not always fully effective against NANC
inhibitory nerve-mediated responses (see Currò, 2010) and lacks efficacy
against certain cholinergically mediated responses to vagal nerve stimu-
lation (guinea pig oesophagus; Kerr et al., 1995) or P/Q-type calcium
current operating Cav2 channel subunits (Alexander et al., 2021). Fur-
ther, efficacy may be limited by the use of high frequencies of nerve
stimulation (e.g., Van Geldre & Lefebvre, 2004; Zygmunt et al., 1993).
Further studies are needed to investigate other neurotoxins to
completely exclude involvement of neurones (e.g. botulinum toxin).
The present experiments do not identify the origin of the hypo-
thesised non-neuronal ACh, but potential sources are suggested
which could be investigated using immunohistochemistry to identify
locations of synthetic and degradative enzymes in addition to
receptors.
5 | CONCLUSIONS
The LALF contractions, argued to reflect predominantly antral activity,
have myogenic origin involving pacemaker cell activity and muscarinic
receptor activation by non-neuronal ACh. This finding is comparable
with the bladder (Zagorodnyuk et al., 2009). Key questions remain.
What is the origin(s) of the ACh (e.g. TTX-insensitive neurones and
epithelium)? What is the stimulus for its release (e.g. antral distension,
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muscle contraction, bacteria, luminal hypoxia or pH)? Does ACh act
directly (e.g. muscle and ICC) or indirectly via release of other sub-
stances? Nevertheless, if replicated, the data indicate that gastric
motor control in mice (and potentially other species) is dependent at
least in part on non-neuronal ACh interacting with the ICC, most likely
those in the distal stomach. The latter has implications in understand-
ing the mechanisms by which gastric motility is disrupted during disor-
ders in which nausea and dysrhythmic gastric electrical activity are
reported (O'Grady et al., 2014).
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